Fluoroalkane modified cationic polymers for personalized mRNA cancer vaccines
Delivery carriers are a critical component in the development of mRNA vaccines. Here, we describe the synthesis of a cationic polymer as a carrier for mRNA cancer vaccine delivery. In vivo results show that this polymer-based mRNA vaccine significantly delays tumor growth after vaccination of mice.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9743697/
Fluoroalkane modified cationic polymers for personalized mRNA cancer vaccine-CEJ 2023 Jan
Related Content
Viruses have well-established causal roles in numerous human cancers. Approximately 10% of cancers globally are attributed to viral infections, primarily...
VIEW RESOURCECasitas B lymphoma-b (Cbl-b), a RING finger E3 ubiquitin ligase, is a key regulator of T cell activation and plays...
VIEW RESOURCE